Pharma · Private company
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma
Track this companyFree. Adds Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma to your Dealase workspace and tells you when its record changes.
Clinical trials63 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- Efficacy of Ra-223 in PSMA PET Optimally Selected PatientsPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 30, 2024ClinicalTrials.gov NCT05924672 · fetched Nov 12, 2026
- A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor AntagonistsPHASE3 · RECRUITING · started Aug 20, 2024ClinicalTrials.gov NCT06033950 · fetched Nov 12, 2026
- A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)PHASE3 · RECRUITING · started Jul 9, 2024ClinicalTrials.gov NCT06024746 · fetched Nov 12, 2026
- Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With CirrhosisPHASE4 · COMPLETED · started Apr 27, 2018ClinicalTrials.gov NCT04288323 · fetched Nov 12, 2026
- Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone MetastasesPHASE2 · TERMINATED · started Apr 1, 2016ClinicalTrials.gov NCT02582749 · fetched Nov 12, 2026
- Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOXPHASE2 · TERMINATED · started Mar 26, 2015ClinicalTrials.gov NCT02425683 · fetched Nov 12, 2026